Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 5/31/2025NMPA Issues New Regulations on Experimental Research of Narcotic and P...
  • 5/31/2025NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...
  • 5/29/2025CDE Solicits Comments on Draft Technical Considerations for NMR Studi...
  • 5/29/2025CDE Issues Guideline on Production Site Change Research for Licensed B...
  • 5/29/2025CDE Launches “Starlight Plan” to Encourage Pediatric Antitumor Drug ...
  • 5/29/2025CDE Issues Guideline on Safety Assessment and Reporting in Pediatric D...
  • 5/22/2025CDE Issues the Guideline on Clinical Trials for Alzheimer's Disease Dr...
  • 5/20/2025CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...
  • 5/20/2025CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...
  • 5/20/2025CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...
  • 5/20/2025CDE Solicits Comments on the 94th Batch of Reference Formulations for ...
  • 5/16/2025NMPA Orders Package Insert/Label Update for Ranitidine Injection Amid ...
  • 5/14/2025CDE Issues the List of Reference Formulations for GQCE Studies (92nd B...
  • 5/14/2025Six Drugs Granted Priority Review as China Registers Over 1,100 Produc...
  • 5/7/2025CDE Seeks Comments on Draft Guidelines for Subject Selection in Bioequ...
  • 5/7/2025CDE Publicizes the List of Reference Formulations for Generic Chemical...
  • 5/6/2025China Seeks Feedbacks on Draft Guideline for Risk Management Plan Duri...
  • 5/6/2025China Seeks Feedbacks on ICH Q1 Stability Testing Guideline Draft
  • 5/6/2025China Announces Ambitious Plan to Optimize Primary Healthcare System b...
  • 4/29/2025China NMPA Suspends Digoxin API Imports from VITAL LABS
  • 4/22/2025China Seeks Feedback on ICH Draft Guideline M13B for Biowaivers of Add...
  • 4/22/2025CDE Issues the List of Reference Formulations for GQCE Studies (91st B...
  • 4/19/2025China Issues New Guidelines to Streamline Mainland Registration for Or...
  • 4/10/2025China Revises Military Drug Administration Measures to Strengthen Over...
  • 4/8/2025CDE Solicits Comments on Draft Q&A for CMC Issues in rAAV-Based In Vi...
  • 4/7/2025China Receives 2.6 Million ADR Reports in 2024, Severe Cases Make Up 1...
  • 4/7/2025NMPA Mandates Digital QR Code System for Drug Manufacturing Licenses
  • 4/7/2025NMPA Solicits Comments on the Announcement on Matters Related to the I...
  • 4/5/2025China and WHO Collaborate on Quality Management Training to Boost Vacc...
  • 3/31/2025CDE Solicits Comments on the Draft Technical Specification of ICH M11:...
  • Page:1/8 Total number of articles:221: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group